Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer. - Feng Y; Deng Y; Tang Z; Cai S; Li J; Liu R; Wan J; He H; Zeng G; Ye J; Han Z; Zhong W (Frontiers in endocrinology, 2023)